{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:54:15Z","timestamp":1787003655843,"version":"build-2736575974"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":52,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["2023-0086\/F1"],"award-info":[{"award-number":["2023-0086\/F1"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-43699-y","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T17:27:00Z","timestamp":1776101220000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Multimodal graphene oxide nanoplatform integrating proteasome inhibition and phototherapy for synergistic oral cancer treatment"],"prefix":"10.1038","volume":"16","author":[{"given":"Shishira","family":"P S","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zinataman","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varshini","family":"Are","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavesha","family":"Chanchlani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankita","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swati","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,13]]},"reference":[{"key":"43699_CR1","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel, R. L., Giaquinto, A. N. & Jemal, A. Cancer statistics, 2024. CA Cancer J. Clin. 74, 12 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"43699_CR2","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.2174\/1567201815666180503120113","volume":"15","author":"H Bhatt","year":"2018","unstructured":"Bhatt, H. et al. Development of curcumin-loaded solid lipid nanoparticles utilizing glyceryl monostearate as single lipid using QbD approach: Characterization and evaluation of anticancer activity against human breast cancer cell line. Curr. Drug Deliv. 15, 1271\u20131283 (2018).","journal-title":"Curr. Drug Deliv."},{"key":"43699_CR3","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.oooo.2013.12.407","volume":"117","author":"P Stefanuto","year":"2014","unstructured":"Stefanuto, P., Doucet, J.-C. & Robertson, C. Delays in treatment of oral cancer: A review of the current literature. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 117, 424\u2013429 (2014).","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"43699_CR4","first-page":"303","volume":"11","author":"S Jitender","year":"2016","unstructured":"Jitender, S., Sarika, G., Varada, H. R., Omprakash, Y. & Mohsin, K. Screening for oral cancer. J. Exp. Ther. Oncol. 11, 303\u2013307 (2016).","journal-title":"J. Exp. Ther. Oncol."},{"key":"43699_CR5","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.oraloncology.2014.09.005","volume":"50","author":"P G\u00fcneri","year":"2014","unstructured":"G\u00fcneri, P. & Epstein, J. B. Late stage diagnosis of oral cancer: Components and possible solutions. Oral Oncol. 50, 1131\u20131136 (2014).","journal-title":"Oral Oncol."},{"key":"43699_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13061321","volume":"13","author":"C Saka-Herran","year":"2021","unstructured":"Saka-Herran, C., Jane-Salas, E., Mari-Roig, A., Estrugo-Devesa, A. & Lopez-Lopez, J. Time-to-treatment in oral cancer: Causes and implications for survival. Cancers (Basel) 13, 1321 (2021).","journal-title":"Cancers (Basel)"},{"key":"43699_CR7","doi-asserted-by":"publisher","DOI":"10.1615\/CritRevOncog.2023046835","author":"R Shah","year":"2023","unstructured":"Shah, R., Shah, H., Thakkar, K. & Parikh, N. Conventional therapies of oral cancers: Highlights on chemotherapeutic agents and radiotherapy, their adverse effects, and the cost burden of conventional therapies. Crit. Rev. Oncog. https:\/\/doi.org\/10.1615\/CritRevOncog.2023046835 (2023).","journal-title":"Crit. Rev. Oncog."},{"key":"43699_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-022-00835-4","volume":"27","author":"C Liu","year":"2022","unstructured":"Liu, C. et al. Tumor microenvironment and immunotherapy of oral cancer. Eur. J. Med. Res. 27, 198 (2022).","journal-title":"Eur. J. Med. Res."},{"key":"43699_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202103895","volume":"9","author":"M Chen","year":"2022","unstructured":"Chen, M. et al. Bortezomib-encapsulated dual responsive copolymeric nanoparticles for gallbladder cancer targeted therapy. Adv. Sci. 9, 2103895 (2022).","journal-title":"Adv. Sci."},{"key":"43699_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22041526","author":"J Qu","year":"2021","unstructured":"Qu, J., Zou, T. & Lin, Z. The roles of the ubiquitin-proteasome system in the endoplasmic reticulum stress pathway. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms22041526 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"43699_CR11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1182\/bloodadvances.2018026880","volume":"3","author":"S Best","year":"2019","unstructured":"Best, S. et al. Targeting ubiquitin-activating enzyme induces ER stress-mediated apoptosis in B-cell lymphoma cells. Blood Adv. 3, 51\u201362 (2019).","journal-title":"Blood Adv."},{"key":"43699_CR12","doi-asserted-by":"crossref","unstructured":"Liu, J., Zhao, R., Jiang, X., Li, Z. & Zhang, B. Progress on the application of bortezomib and bortezomib-based nanoformulations. Biomolecules 12, (2022).","DOI":"10.3390\/biom12010051"},{"key":"43699_CR13","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1200\/JCO.2009.23.8220","volume":"28","author":"E Kastritis","year":"2010","unstructured":"Kastritis, E. et al. Bortezomib with or without dexamethasone in primary systemic (light chain) amyloidosis. J. Clin. Oncol. 28, 1031\u20131037 (2010).","journal-title":"J. Clin. Oncol."},{"key":"43699_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2025.106700","volume":"106","author":"SP S","year":"2025","unstructured":"S, S. P., Paul, M. & Biswas, S. 3,4-Dihydroxyhydrocinnamic acid conjugated methoxy-poly(ethylene glycol)-poly(lactic acid) polymeric micelles for bortezomib delivery and efficacy enhancement in doxorubicin-resistant breast cancer. J. Drug Deliv. Sci. Technol. 106, 106700 (2025).","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"43699_CR15","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1021\/acs.molpharmaceut.4c01283","volume":"22","author":"A Saremi Poor","year":"2025","unstructured":"Saremi Poor, A. et al. Nanoparticle albumin-bound bortezomib: Enhanced antitumor efficacy and tumor accumulation in breast cancer therapy. Mol. Pharm. 22, 2482\u20132493 (2025).","journal-title":"Mol. Pharm."},{"key":"43699_CR16","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s10924-024-03451-x","volume":"33","author":"W Sun","year":"2025","unstructured":"Sun, W. & Li, S. Fabrication of co-delivery of bortezomib and vincristine loaded chitosan cross-linked polymeric nanoparticles: Evaluation of anticancer activity and apoptosis induction in lung cancer cells. J. Polym. Environ. 33, 867\u2013884 (2025).","journal-title":"J. Polym. Environ."},{"key":"43699_CR17","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/php.13184","volume":"96","author":"BC Wilson","year":"2020","unstructured":"Wilson, B. C. & Weersink, R. A. The Yin and Yang of PDT and PTT. Photochem. Photobiol. 96, 219\u2013231 (2020).","journal-title":"Photochem. Photobiol."},{"key":"43699_CR18","doi-asserted-by":"publisher","first-page":"21348","DOI":"10.1021\/acsnano.4c18444","volume":"19","author":"R Zhang","year":"2025","unstructured":"Zhang, R. et al. Valence electron fluctuation in a high-entropy oxide heterojunction enables collaborative photodynamic and mild-thermal therapy for cutaneous biofilm infections. ACS Nano 19, 21348\u201321364 (2025).","journal-title":"ACS Nano"},{"key":"43699_CR19","doi-asserted-by":"publisher","first-page":"7979","DOI":"10.1021\/acsnano.3c00891","volume":"17","author":"M Overchuk","year":"2023","unstructured":"Overchuk, M., Weersink, R. A., Wilson, B. C. & Zheng, G. Photodynamic and photothermal therapies: Synergy opportunities for nanomedicine. ACS Nano 17, 7979\u20138003 (2023).","journal-title":"ACS Nano"},{"key":"43699_CR20","doi-asserted-by":"publisher","first-page":"4431","DOI":"10.2147\/IJN.S247617","volume":"15","author":"Y Jiang","year":"2020","unstructured":"Jiang, Y., Huang, C. & Luan, Y. Lactosylated IR820\/DOX co-assembled nanodrug for synergetic antitumour therapy. Int. J. Nanomed. 15, 4431\u20134440 (2020).","journal-title":"Int. J. Nanomed."},{"key":"43699_CR21","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.nano.2016.11.005","volume":"13","author":"T Duong","year":"2017","unstructured":"Duong, T. et al. Phototheranostic nanoplatform based on a single cyanine dye for image-guided combinatorial phototherapy. Nanomedicine 13, 955\u2013963 (2017).","journal-title":"Nanomedicine"},{"key":"43699_CR22","doi-asserted-by":"publisher","first-page":"6172","DOI":"10.1039\/D2BM00835A","volume":"10","author":"GR Nirmal","year":"2022","unstructured":"Nirmal, G. R. et al. Polydopamine\/IR820 nanoparticles as topical phototheranostics for inhibiting psoriasiform lesions through dual photothermal and photodynamic treatments. Biomater. Sci. 10, 6172\u20136189 (2022).","journal-title":"Biomater. Sci."},{"key":"43699_CR23","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/j.biopha.2018.07.049","volume":"106","author":"S Kwiatkowski","year":"2018","unstructured":"Kwiatkowski, S. et al. Photodynamic therapy - mechanisms, photosensitizers and combinations. Biomed. Pharmacother. 106, 1098\u20131107 (2018).","journal-title":"Biomed. Pharmacother."},{"key":"43699_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioadv.2023.213550","volume":"153","author":"AM Itoo","year":"2023","unstructured":"Itoo, A. M., Paul, M., Ghosh, B. & Biswas, S. Polymeric graphene oxide nanoparticles loaded with doxorubicin for combined photothermal and chemotherapy in triple negative breast cancer. Biomater. Adv. 153, 213550 (2023).","journal-title":"Biomater. Adv."},{"key":"43699_CR25","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.jmst.2016.06.014","volume":"32","author":"G Chang","year":"2016","unstructured":"Chang, G. et al. Multifunctional reduced graphene oxide hydrogel as drug carrier for localized and synergic photothermal\/photodynamics\/chemo therapy. J. Mater. Sci. Technol. 32, 753\u2013762 (2016).","journal-title":"J. Mater. Sci. Technol."},{"key":"43699_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/cells9030776","volume":"9","author":"MJ Podolska","year":"2020","unstructured":"Podolska, M. J. et al. Graphene oxide nanosheets for localized hyperthermia\u2014Physicochemical characterization, biocompatibility, and induction of tumor cell death. Cells 9, 776 (2020).","journal-title":"Cells"},{"key":"43699_CR27","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.msec.2018.04.096","volume":"90","author":"B Wang","year":"2018","unstructured":"Wang, B. et al. Synthesis of polymer-functionalized nanoscale graphene oxide with different surface charge and its cellular uptake, biosafety and immune responses in Raw264.7 macrophages. Mater. Sci. Eng. C Mater. Biol. Appl. 90, 514\u2013522 (2018).","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"key":"43699_CR28","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1126\/science.1147241","volume":"318","author":"H Lee","year":"2007","unstructured":"Lee, H., Dellatore, S. M., Miller, W. M. & Messersmith, P. B. Mussel-inspired surface chemistry for multifunctional coatings. Science 318, 426\u2013430 (2007).","journal-title":"Science"},{"key":"43699_CR29","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1021\/acsabm.8b00718","volume":"2","author":"R Chen","year":"2019","unstructured":"Chen, R. et al. Polydopamine-based multifunctional platform for combined photothermal therapy, chemotherapy, and immunotherapy in malignant tumor treatment. ACS Appl. Bio Mater. 2, 874\u2013883 (2019).","journal-title":"ACS Appl. Bio Mater."},{"key":"43699_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioadv.2024.214121","volume":"168","author":"AM Itoo","year":"2025","unstructured":"Itoo, A. M. et al. Biotinylated platinum (IV)-conjugated graphene oxide nanoparticles for targeted chemo-photothermal combination therapy in breast cancer. Biomater. Adv. 168, 214121 (2025).","journal-title":"Biomater. Adv."},{"key":"43699_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2022.119108","volume":"282","author":"AM Itoo","year":"2022","unstructured":"Itoo, A. M., Paul, M., Ghosh, B. & Biswas, S. Oxaliplatin delivery via chitosan\/vitamin E conjugate micelles for improved efficacy and MDR-reversal in breast cancer. Carbohydr. Polym. 282, 119108 (2022).","journal-title":"Carbohydr. Polym."},{"key":"43699_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.molliq.2020.114389","author":"S Kumbham","year":"2020","unstructured":"Kumbham, S., Paul, M., Bhatt, H., Ghosh, B. & Biswas, S. Oleanolic acid-conjugated poly (D, L-lactide)-based micelles for effective delivery of doxorubicin and combination chemotherapy in oral cancer. J. Mol. Liq. https:\/\/doi.org\/10.1016\/j.molliq.2020.114389 (2020).","journal-title":"J. Mol. Liq."},{"key":"43699_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.molliq.2020.114389","volume":"320","author":"S Kumbham","year":"2020","unstructured":"Kumbham, S., Paul, M., Bhatt, H., Ghosh, B. & Biswas, S. Oleanolic acid-conjugated poly (D, L-lactide)-based micelles for effective delivery of doxorubicin and combination chemotherapy in oral cancer. J. Mol. Liq. 320, 114389 (2020).","journal-title":"J. Mol. Liq."},{"key":"43699_CR34","doi-asserted-by":"publisher","first-page":"19710","DOI":"10.1021\/acsanm.3c03499","volume":"6","author":"S Das","year":"2023","unstructured":"Das, S., Paul, M., Ghosh, B. & Biswas, S. Synergistic anticancer response via docetaxel-and oleanolic acid-loaded albumin\/poly (lactide) nanoparticles in triple-negative breast cancer. ACS Appl. Nano Mater. 6, 19710\u201319726 (2023).","journal-title":"ACS Appl. Nano Mater."},{"key":"43699_CR35","first-page":"1","volume":"85","author":"M Paul","year":"2024","unstructured":"Paul, M., Ghosh, B. & Biswas, S. F127\/chlorin e6-nanomicelles to enhance Ce6 solubility and PDT-efficacy mitigating lung metastasis in melanoma. Drug Deliv. Transl. Res. 85, 1\u201317 (2024).","journal-title":"Drug Deliv. Transl. Res."},{"key":"43699_CR36","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.4c00723","author":"KS Maravajjala","year":"2024","unstructured":"Maravajjala, K. S. et al. Synergistic chemo-immunotherapy using pH-responsive nanoparticles in breast cancer treatment: In vitro and in vivo studies. Mol. Pharm. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.4c00723 (2024).","journal-title":"Mol. Pharm."},{"key":"43699_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2022.121479","volume":"614","author":"S Kumbham","year":"2022","unstructured":"Kumbham, S., Paul, M., Itoo, A., Ghosh, B. & Biswas, S. Oleanolic acid-conjugated human serum albumin nanoparticles encapsulating doxorubicin as synergistic combination chemotherapy in oropharyngeal carcinoma and melanoma. Int. J. Pharm. 614, 121479 (2022).","journal-title":"Int. J. Pharm."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43699-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43699-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43699-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:19:46Z","timestamp":1780532386000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43699-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,13]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["43699"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-43699-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8213640\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,13]]},"assertion":[{"value":"26 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17318"}}